earnings
AN
NASDAQ · ANTX
AN2 Therapeutics, Inc.
Healthcare · Biotechnology
$4.00
Up+$0.00 (+0.00%)
Updated Nov 9, 2026, 4:37 PM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 30.14M
- P/E ratio
- -0.98
- Dividend yield
- 0.00%
- 52-week range
- $1.00 – $7.19
- Volume
- 240.36K
- Avg. volume
- 90.8K
Price performance · ANTX
ANTX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 6, 2026
ANTX closed at $4.00 after 20 trading sessions, down 6.98% for the selected period.
- Last close
- $4.00
- Period change
- -6.98%
- Period low
- $3.37
- Period high
- $4.69
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | $3.99 | $4.11 | $3.90 | $4.00 | 240.36K |
| Nov 5, 2026 | $4.22 | $4.255 | $3.82 | $3.955 | 152.97K |
| Nov 4, 2026 | $4.22 | $4.31 | $4.10 | $4.25 | 131.83K |
| Nov 3, 2026 | $4.38 | $4.55 | $4.10 | $4.18 | 160.4K |
| Nov 2, 2026 | $4.54 | $4.64 | $4.2411 | $4.35 | 299.61K |
| Oct 30, 2026 | $4.66 | $4.76 | $4.31 | $4.53 | 284.72K |
| Oct 29, 2026 | $4.57 | $4.90 | $4.53 | $4.69 | 555.79K |
| Oct 28, 2026 | $3.86 | $4.60 | $3.85 | $4.52 | 545.42K |
| Oct 27, 2026 | $3.61 | $3.89 | $3.54 | $3.86 | 239.63K |
| Oct 26, 2026 | $3.55 | $3.70 | $3.50 | $3.63 | 196.18K |
| Oct 23, 2026 | $3.61 | $3.6599 | $3.47 | $3.55 | 124.44K |
| Oct 22, 2026 | $3.57 | $3.72 | $3.521 | $3.64 | 95.19K |
| Oct 21, 2026 | $3.58 | $3.78 | $3.57 | $3.60 | 177.37K |
| Oct 20, 2026 | $3.38 | $3.59 | $3.36 | $3.56 | 129.74K |
| Oct 19, 2026 | $3.39 | $3.46 | $3.21 | $3.37 | 330.87K |
| Oct 16, 2026 | $3.60 | $3.62 | $3.30 | $3.38 | 281.73K |
| Oct 15, 2026 | $3.50 | $3.69 | $3.50 | $3.60 | 295.94K |
| Oct 14, 2026 | $3.55 | $3.73 | $3.33 | $3.54 | 431.03K |
| Oct 13, 2026 | $4.30 | $4.32 | $3.59 | $3.60 | 515.05K |
| Oct 12, 2026 | $4.41 | $4.41 | $4.24 | $4.30 | 298.47K |
Latest ANTX news
The latest Smart Investors Daily articles mentioning ANTX.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

